Title: Ballard v. Takeda Pharmaceuticals America, Inc., et al.
Citation: N/A
Docket Number: 361, 2017
State: Delaware
Issuer: Delaware Supreme Court
Date: April 23, 2018

IN THE SUPREME COURT OF THE STATE OF DELAWARE 
 
ELISHA BALLARD, 
§ 
 
§ 
No. 361, 2017 
 
Plaintiff Below, 
§ 
 
Appellant, 
§ 
 
 
§ 
Court Below:  The Superior Court 
 
v. 
§ 
of the State of Delaware 
 
 
§ 
TAKEDA PHARMACEUTICALS 
§ 
C.A. No. N16C-10-177 JRJ 
AMERICA, INC., TAKEDA  
§ 
PHARMACEUTICALS U.S.A., 
§ 
INC., f/k/a TAKEDA  
§ 
PHARMACEUTICALS NORTH  
§ 
AMERICA, INC., TAKEDA  
§ 
PHARMACEUTICAL COMPANY 
§ 
LIMITED, and ELI LILLY AND 
§ 
COMPANY, 
§ 
 
 
§ 
Defendants Below,  
§ 
Appellees. 
§ 
 
Submitted:   April 18, 2018 
Decided:   April 23, 2018 
 
Before STRINE, Chief Justice; SEITZ, and TRAYNOR, Justices. 
 
O R D E R 
 
This 23rd day of April 2018, it appears to the Court that the judgment of the 
Superior Court should be affirmed on the basis of its opinion dated August 7, 2017.1   
 
 
                                                 
1 Ballard v. Takeda Pharm. Am., Inc., 2017 WL 3396488 (Del. Super. Ct. Aug. 7, 2017). 
2 
NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior 
Court is hereby AFFIRMED. 
 
 
 
 
 
BY THE COURT:  
 
 
 
 
 
 
 
 
/s/ Leo E. Strine, Jr. 
 
 
 
 
 
 
 
 
Chief Justice